Insulin receptor non-peptide small molecule agonist of the research.docVIP

Insulin receptor non-peptide small molecule agonist of the research.doc

  1. 1、本文档共10页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Insulin receptor non-peptide small molecule agonist of the research

 PAGE \* MERGEFORMAT 10 Insulin receptor non-peptide small molecule agonist of the research [Abstract] has found a number of non-peptide small molecules that can simulate the role of insulin activation of insulin receptor-mediated signal transduction pathway for the development of new anti-diabetes drugs provide a new strategy. This paper reviews the insulin receptor at home and abroad in recent years, non-peptide small molecule agonist of research progress, to discuss traditional Chinese medicine were screened from the insulin receptor non-peptide small molecule agonist prospects. [Keywords:] insulin receptor; non-peptide small molecule agonist; traditional Chinese medicine Diabetes is the most common endocrine disease. With the development of production, improved living standards and population life expectancy, the rapidly growing incidence of diabetes has become a global medical problem. At present, all patients with type 1 diabetes and oral diabetes drugs control blood glucose levels in patients with type 2 diabetes need to use insulin therapy. However, insulin is a peptide molecule, oral digestion would be the loss of activity, but rely on injections for treatment, cause great inconvenience to the patient and suffering. Therefore, looking for oral non-peptide small molecule agonist of insulin will be cause for concern. China’s rich resources of Chinese medicine, Chinese medicine treatment of diabetes has a long history, development and effective use of Chinese medicine with anti-diabetic effects, from screening extracts of insulin receptor non-peptide small molecule agonist, on China’s pharmaceutical industry is significant. An insulin receptor non-peptide small molecule agonist of the research significance Diabetes is generally divided into type 1 diabetes and type 2 diabetes. Type 1 diabetes is usually due to pancreatic islet β -cell secretion of insulin which led to reduced capacity due to a lack of insulin; the cause of type 2 diabetes are very

您可能关注的文档

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档